Addition of Dasatinib to Induction/Consolidation Fails to Boost Survival in Core-Binding Factor AML
Talquetamab/Cetrelimab Leads to Deep, Durable Responses in R/R Multiple Myeloma
Dr Curtis on Cyclophosphamide GVHD Prophylaxis in Matched Donor Transplant
Dr Ku on the Safety Profile of JNJ-90014496 in Relapsed/Refractory LBCL